why choose us

First received: October 19, 2023

Clinical Trial: Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Sepsis

Study Type: OBSERVATIONAL


Official Title: Discharge Readmission Analysis and Management in Sepsis (DReAMS-2): Augmenting Readmission Risk Models With Smartphone PPG Signals and Deep Learning, an Adaptive Platform

Brief Summary: This is an adaptive platform.This study is being done to collect information that will help us identify trends in patients with sepsis and other health conditions being readmitted into hospitals within 30 days of being discharged.This information will be used to create a computer tool that will help predict a patient's risk of being readmitted into the hospital after being discharged.Participants will allow the study team to follow their health after they are discharged by taking their temperature once a day…

Read more